1 month ago
3
PULSE POINTS:
❓What Happened: A Palestinian illegal immigrant and alleged terrorist has been jailed for just nine months after attempting illegal entry into the United Kingdom by small boat.
👥 Who’s Involved: Abu Wadee, also known as Mosab Abdulkarim Al-Gassas; Judge Sarah Counsell; terrorism expert Joe Truzman.
Your free, daily feed from The National Pulse.
📍 Where & When: Initially arrested in Kent, England, on March 6, 2024, after crossing the Channel.
💬 Key Quote: “There is legitimate public concern about breaches of border control,” Judge Sarah Counsell said, despite handing down a light sentence for the accused Palestinian terrorist.
⚠️ Impact: Wadee’s arrival raised security concerns due to his militant ties and rhetoric targeting Jews. His light prison sentence for illegally crossing the English Channel into the United Kingdom raises concerns about how the British justice system is handling cases involving dangerous foreign nationals who are illegally entering the country.
IN FULL:
A Palestinian man with alleged ties to Islamist militant groups and a history of anti-Semitic rhetoric has been sentenced to just nine months in prison for attempting to enter the United Kingdom illegally. Abu Wadee, also known as Mosab Abdulkarim Al-Gassas, pleaded guilty at Canterbury Crown Court after crossing the English Channel in a small boat on March 6, 2025, without valid entry clearance. Wadee, 33, reportedly paid smugglers €1,500 (£1,300 or $1,700) to facilitate the journey and was arrested upon arrival in Kent, England.
The court heard that Wadee, who left Gaza in 2022, had previously sought asylum in Greece, Germany, and Belgium. He had no familial or financial ties to the United Kingdom and stayed in northern France for about a week before attempting the crossing. Judge Sarah Counsell highlighted the public concern over illegal boat crossings, noting the dangers involved and the profits gained by organized criminals.
Bizarrely, Judge Counsell took a moment to chastize Wadee directly, not over his ties to terrorism or violent speech towards Jewish people, but rather over his decision to cross the English Channel. The judge warned Wadee that the illegal crossing posed a significant “risk of death or injury to you and others.”
Meanwhile, videos and images posted online show Wadee expressing support for Hamas, calling for violence against Jews, and posing with an assault rifle. In one Facebook video, he reportedly called for Allah to “punish [Jews] completely.”
Terrorism expert Joe Truzman stated that Wadee had been affiliated with Gaza-based terror groups, including the Hamas-aligned Al-Qadir al-Husseini Brigades. Truzman added that Wadee gained notoriety during the Great March of Return protests from 2018 to 2022, where he participated in violent clashes at the Gaza-Israel border.
Footage obtained by The Telegraph allegedly shows Wadee throwing pipe bombs during confrontations with Israeli forces in 2021. He has also amassed a significant online following, with 170,000 TikTok followers and 189,000 YouTube subscribers.
PULSE POINTS:
❓What Happened: Regeneron has agreed to purchase 23andMe for $256 million through a court-supervised bankruptcy sale.
👥 Who’s Involved: Regeneron Pharmaceuticals, 23andMe, Anne Wojcicki (former CEO), Joe Selsavage (interim CEO).
Your free, daily feed from The National Pulse.
📍 Where & When: The deal was announced Monday; 23andMe filed for bankruptcy in March 2025.
💬 Key Quote: “We are pleased to reach an agreement with a science-driven partner that maintains our team and helps ensure our mission will carry forward,” said Joe Selsavage, 23andMe’s interim CEO.
⚠️ Impact: Regeneron will acquire 23andMe’s genetic testing and research assets but not its telehealth business, while committing to uphold privacy laws and policies.
IN FULL:
Regeneron Pharmaceuticals has finalized a $256 million agreement to acquire genetic testing company 23andMe, following the latter’s bankruptcy filing earlier this year. The purchase, made under a court-supervised sale process, includes 23andMe’s genetic testing services and health research assets but excludes its Lemonaid Health telehealth division.
Notably, President Donald J. Trump received a dose of a Regeneron antibody drug in late 2020 when he was diagnosed with COVID-19. At the time, the medication was still in an experimental phase, but showed promise as a treatment for the virus.
The consumer genetic testing company 23andMe filed for bankruptcy in March 2025, citing financial difficulties. At the time, it announced plans to seek a buyer and confirmed the resignation of its co-founder and CEO, Anne Wojcicki.
Under the terms of the agreement, Regeneron, based in Tarrytown, New York, will continue to provide 23andMe’s consumer genetic services without interruption. The company also emphasized its commitment to adhering to 23andMe’s existing privacy policies and applicable laws to safeguard sensitive customer information.
“We have deep experience with large-scale data management,” said George Yancopoulos, Regeneron’s co-founder, in a statement. He added: “With the consent of individuals, we use this data to drive discoveries that benefit science and society, while maintaining a strong track record of protecting genetic data.”
Privacy concerns have surrounded 23andMe’s vast database, which includes the DNA information of approximately 15 million customers. The company’s services allow users to explore their ancestry and genetic health profiles, including identifying potential hereditary risks. Its research wing has also been involved in developing treatments for cancer, immune disorders, and other conditions.
Interim CEO Joe Selsavage expressed optimism about the acquisition, stating, “We are pleased to reach an agreement with a science-driven partner that maintains our team and helps ensure our mission will carry forward. With Regeneron’s expertise in genetic sequencing, testing, and discovery, we look forward to continuing to help people access and understand the human genome for the benefit of customers and patients.”
show less
English (US) ·